Pulmonary sarcoidosis is a disorder of the lower respiratory tract of unknowncause characterized by chronic inflammation, granuloma formation, and alveolitis, with parenchymal fibrosis in some patients (1) (2) (3) . These changes occur in the alveoli, and blood vessels, and impair gas exchange (4) . Recently, the concept of immunopathogenesisof disease has been proposed from studies on inflammatory cells recovered from the lung by bronchoalveolar lavage (BAL) (5) . Active pulmonary sarcoidosis is characterized by the accumulation of active helper T lymphocytes in the lung (1, 2, 6, 7) . The activated T cells at the site of disease proliferate and release mediators, such as interleukin 2 (IL-2) (6, 7), and these T cells are thought to be important in the pathogenesis of sarcoidosis.
IL-2 is a T cell-derived lymphokine that has various effects, such as induction of T cell proliferation. The expression of the receptor for IL-2 is greatly increased in conditions that cause T cell activation (8) . Moreover, a soluble form of IL-2 receptor (IL-2R) is released by activated T cells and has been shownto be a sensitive marker for T cell activation in vitro (9, 10 BALwas performed using a flexible fiberoptic bronchoscope as described previously (12) . Briefly, the bronchoscope (Olympus Model BFIT 20) was wedgedinto a segmental or subsegmental bronchus of the middle lobe. Lavage was performed three times with 50 ml of saline solution. The BALFwas centrifuged at 250 x g for 10 min to collect cells. The total cell number was counted in a haemocytometer, and cell differentiation was performed by May- were saturated with PBS containing 1%bovine serum albumin. The plates were again washed and samples were introduced and incubated for 60 min at 37°C. The plates were then washed and incubated with biotinylated monoclonal antibody IgG for 60 min at 37°C. The plates were washed again and incubated with streptoavidin-/3 -D-galactosidase.
The absorbance was measured using excitation and emission wavelengths of 360 and 450 nm, respectively.
The levels of soluble IL-2R were calculated from a standard curve, and expressed as units of soluble IL-2R per ml of BALF.
RESULTS
Concentration of soluble IL-2R in BALFobtained from normal subjects and sarcoidosis patients The levels of soluble IL-2R in BALFof normal subjects and sarcoidosis patients are comparedin Fig. 1 . The mean level of soluble IL-2R in the BALF of the patients (2.8 ±0.9 U/ml) was significantly higher than that in the normal subjects (0.1 ±0.1 U/ml) (p<0.01). Soluble IL-2R was detected in the BALFof about half of the patients with sarcoidosis, but in only one normal subject, in.whom the level 3 ). Four patients with parenchymal involvement were followed up for more than 1 yr. In three patients with detectable IL-2R in BALF, no change in chest X-ray examination was found, but in a patient with no detectable IL-2R in BALF, an abnormal shadow of the lung field improved. Moreover, a soluble form of their receptor has been found in human sera and in the supernatant of stimulated lymphocytes (9) . This finding in a certain disease state has indicated that abnormal levels of secreted IL-2R are associated with excessive lymphocyte activation related to a significant immunologic disorder (21, 22 
